Hwail Pharm Co., Ltd. logo

Hwail Pharm Co., Ltd. (061250)

Market Closed
11 Aug, 06:30
KRX SM KRX SM
8,840. 00
-30
-0.3382%
67.51B Market Cap
- P/E Ratio
1,666.67% Div Yield
2,072 Volume
- Eps
8,870
Previous Close
Add Transaction
Day Range
8,700 8,990
Year Range
7,090 13,800
Want to track 061250 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Hwail Pharm Co., Ltd. (061250) Statistics

Valuation metrics

Market Cap 67.51B
Enterprise value 36.53B
Trailing P/E (ttm) -267.33
Forward P/E -
PEG ratio 1.43
Price/Sales (ttm) 0.67
Price/Book (mrq) 0.32
Enterprise Value/Revenue 0.34
Enterprise Value/EBITDA 7.03

Overview

Shares outstanding 8.42M
Float 2.23M
Shares short -
% Held by insiders 0.45%
% Held by institutions 0%
Average volume (10 days) 27.79K
Average volume (90 days) 26.99K

Price summary

52-Week low 7,090
52-Week high 13,800
Beta 0.21
50-Day moving average 9,643.4
200-Day moving average 10,982.6

Dividends and splits

Forward annual dividend rate 1,666.67
Forward annual dividend yield 0.2078%
Trailing annual dividend rate 416.67
Trailing annual dividend yield 0.052%
5-Year annual dividend yield 1.93%
Payout ratio -
Dividend Date 5 Jan 2021
Ex-Dividend Date 29 Dec 2020
Last split factor 0.1:1
Last split Date 7 Apr 2026

Financials

Fiscal year

Fiscal year ends 31 Dec 2016
Most recent quarter (mrq) 31 Mar 2026

Profitability

Profit margin 0.02%
Operating margin 0.06%

Operational effectiveness

Return on assets 0.01%
Return on equity 0.02%

Income Statement

Revenue (ttm) 107.87B
Revenue per share (ttm) 26,591.18
Quarterly revenue growth (yoy) -0.12%
Gross profit (ttm) 14.09B
EBITDA 623.78M
Net income to common (ttm) 1.92B
Diluted EPS (ttm) -30
Quarterly earnings growth (yoy) -0.83%

Balance Sheet

Total cash (mrq) 11.83B
Total cash per share (mrq) 2,916.25
Total debt (mrq) 15.83B
Total Debt/Equity (mrq) 16.15
Current ratio (mrq) 3.67%
Book value per share (mrq) 25,217.44

Cash Flow

Cash flow statement 11.2B
Levered free cash flow (LFCF) 9.91B